185 related articles for article (PubMed ID: 38067325)
1. Spatial Distribution of Non-Immune Cells Expressing Glycoprotein A Repetitions Predominant in Human and Murine Metastatic Lymph Nodes.
Rouaud L; Baudin L; Gautier-Isola M; Van Meerbeeck P; Feyereisen E; Blacher S; van Baren N; Kridelka F; Lucas S; Noel A
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067325
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.
Huygens C; Liénart S; Dedobbeleer O; Stockis J; Gauthy E; Coulie PG; Lucas S
J Biol Chem; 2015 Aug; 290(33):20105-16. PubMed ID: 26126825
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation.
Edwards JP; Fujii H; Zhou AX; Creemers J; Unutmaz D; Shevach EM
J Immunol; 2013 Jun; 190(11):5506-15. PubMed ID: 23645881
[TBL] [Abstract][Full Text] [Related]
4. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
Zhou AX; Kozhaya L; Fujii H; Unutmaz D
J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
[TBL] [Abstract][Full Text] [Related]
5. Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patients.
Jin H; Sun L; Tang L; Yu W; Li H
Front Immunol; 2017; 8():138. PubMed ID: 28261204
[TBL] [Abstract][Full Text] [Related]
6. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Responses of Subcapsular Sinus Floor Lymphatic Endothelial Cells in Tumor-Draining Lymph Nodes.
Sibler E; He Y; Ducoli L; Rihs V; Sidler P; Puig-Moreno C; Frey J; Fujimoto N; Detmar M; Dieterich LC
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892863
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells express GARP/LRRC32 on their surface: effects on their biology and immunomodulatory capacity.
Carrillo-Galvez AB; Cobo M; Cuevas-Ocaña S; Gutiérrez-Guerrero A; Sánchez-Gilabert A; Bongarzone P; García-Pérez A; Muñoz P; Benabdellah K; Toscano MG; Martín F; Anderson P
Stem Cells; 2015 Jan; 33(1):183-95. PubMed ID: 25182959
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.
Nookala S; Mukundan S; Fife A; Alagarsamy J; Kotb M
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
[TBL] [Abstract][Full Text] [Related]
11. GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.
Zimmer N; Trzeciak ER; Graefen B; Satoh K; Tuettenberg A
Front Immunol; 2022; 13():928450. PubMed ID: 35898500
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex.
Niu J; Yue W; Le-Le Z; Bin L; Hu X
Oncotarget; 2017 Nov; 8(59):99784-99800. PubMed ID: 29245940
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
[TBL] [Abstract][Full Text] [Related]
14. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
[TBL] [Abstract][Full Text] [Related]
15. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.
Tran DQ; Andersson J; Wang R; Ramsey H; Unutmaz D; Shevach EM
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13445-50. PubMed ID: 19651619
[TBL] [Abstract][Full Text] [Related]
16. GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment.
Bouchard A; Collin B; Garrido C; Bellaye PS; Kohli E
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571713
[TBL] [Abstract][Full Text] [Related]
17. GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing.
Sun L; Jin H; Li H
Oncotarget; 2016 Jul; 7(27):42826-42836. PubMed ID: 27095576
[TBL] [Abstract][Full Text] [Related]
18. Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors.
Vermeersch E; Liénart S; Collignon A; Lucas S; Gallimore A; Gysemans C; Unutmaz D; Vanhoorelbeke K; De Meyer SF; Maes W; Deckmyn H
Cell Immunol; 2018 Oct; 332():129-133. PubMed ID: 30093071
[TBL] [Abstract][Full Text] [Related]
19. Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.
Gaignage M; Zhang X; Stockis J; Dedobbeleer O; Michiels C; Cochez P; Dumoutier L; Coulie PG; Lucas S
Cancer Immunol Immunother; 2022 Aug; 71(8):1851-1862. PubMed ID: 34973084
[TBL] [Abstract][Full Text] [Related]
20. CD4
Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
